All News

Don't be ashamed that you haven't "moved on," says this metastatic breast cancer patient.

The role of precision medicine has become a significant area of study, specifically with genomics and liquid biopsies. With the introduction of next-generation sequencing and an improvement in the understanding of molecular alterations, treatments for patients have begun to be individualized.

New discoveries happen often. Is there one for us?

Breast cancer and melanoma survivor reflects about being tired of her cancers and shares a way to respond to uncertainty.

NextSource Pharma, a small pharmaceutical company based in Florida, acquired the drug lomustine from Bristol-Myers Squibb, changed its brand name to Gleostine, and changed the price – by about 1,400 percent.

Xgeva (denosumab) was granted approval by the Food and Drug Administration (FDA) to prevent skeletal-related events (SREs) in patients with multiple myeloma, according to Amgen, the developer of the drug.

A drug commonly used to treat patients with multiple myeloma may lead to an increased risk of cardiovascular events such as heart attacks, according to recent research conducted at the Abramson Cancer Center of the University of Pennsylvania.

Fat cells can harbor extra estrogen. With this in mind, doesn't it make sense for women affected by estrogen-fed cancer to become conscious of their weight?

“As the population of cancer survivors continues to grow, so does the importance of addressing the long-term sequelae of cancer treatment,” the authors wrote. “This hearing loss can result in multifaceted decrease in quality of life, and in pediatric patients it can impact social and academic development.”

"Getting on" with life after a spouse dies is not easy. Forgiving cancer for its domino effect is even harder.

A blog series of words and terms common to the cancer journey by Rick Boulay M.D.

Kisqali (ribociclib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) to be used in combination with tamoxifen or an aromatase inhibitor (AI) in the frontline treatment of pre- or perimenopausal women who have hormone receptor-positive HER2-negative advanced or metastatic breast cancer.

Patients with blood cancers are at an increased risk for multiple hospital readmissions. However, multidisciplinary teams and patients can work together to identify predictors and avoid these occurrences.

Life-saving medical care can leave scars that don't show on the outside, but last a lifetime.

Most Americans have insurance. We find comfort in knowing our future is secure in the event of a health crisis. But how do we know how much insurance is enough? Is it wise to take our specialized policies?

Adcetris (brentuximab vedotin) was granted a priority review to a supplemental biologics license application (sBLA) by the Food and Drug Administration (FDA) to be used in combination with Adriamycin, vinblastine and dacarbazine (AVD) to treat patients with classical Hodgkin lymphoma in the frontline setting, according to Seattle Genetics, the company developing the drug.

Breast cancer, melanoma survivor and clutter-clearing speaker/author clears her cancer and household clutter.

Some cancer survivors are good at getting on with life. Some of us remain timid about the prospect of life, even when a prognosis is good. A new year is a good time to try harder to seize the day, whatever the future is likely to bring.

The Food and Drug Administration (FDA) granted a priority review designation to a novel version of Azedra (iobenguane I-131), a radiopharmaceutical, to treat patients with malignant or recurrent pheochromocytoma or paraganglioma (PPGL).

It is hard to start a new year in the middle of cancer treatment. That was the situation for me, and I recall grasping at anything positive I could find in the coming of a new year.

A study of 1,334 men diagnosed with non-metastatic prostate cancer showed a significantly increased risk of recurrence in those who consumed more than four servings of whole milk per week.

A poem reflecting on one survivor's feelings on bras.

My New Year's resolutions include never becoming complacent.

Researchers found a significant trend toward increased hospice use by people who have multiple myeloma between 2010 and 2013, which indicates that they are receiving more effective pain management toward the end of their lives.

Five simple, doable resolutions for the New Year from a breast cancer and melanoma survivor.

Patients diagnosed with thyroid cancer before the age of 40 appear to be at the highest risk for age-related diseases, including heart disease and diabetes, compared with their age-matched counterparts.

Let's recognize time as the gift it is, and chart a course for making 2018 really count.

Instead of making the same old New Year's resolutions, why not try something different? Go after what you really want for a new year and really live it.